BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 20676870)

  • 21. [Epidemiology and pathophysiology of Barrett esophagus].
    Freys SM; Fuchs KH; Heimbucher J; Fein M; Thiede A
    Zentralbl Chir; 2000; 125(5):406-13. PubMed ID: 10929624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progression to cancer in Barrett's esophagus is associated with genomic instability.
    Rabinovitch PS; Reid BJ; Haggitt RC; Norwood TH; Rubin CE
    Lab Invest; 1989 Jan; 60(1):65-71. PubMed ID: 2911184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Barrett's metaplasia develops from cellular reprograming of esophageal squamous epithelium due to gastroesophageal reflux.
    Minacapelli CD; Bajpai M; Geng X; Cheng CL; Chouthai AA; Souza R; Spechler SJ; Das KM
    Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G615-G622. PubMed ID: 28336546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Columnar metaplasia in the esophageal remnant after esophagectomy: a systematic review.
    Dunn LJ; Shenfine J; Griffin SM
    Dis Esophagus; 2015 Jan; 28(1):32-41. PubMed ID: 24224923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
    Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
    Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duodenal juice stimulates oesophageal stem cells to induce Barrett's oesophagus and oesophageal adenocarcinoma in rats.
    Miyashita T; Ohta T; Fujimura T; Ninomiya I; Fushida S; Hattori T; Miwa K
    Oncol Rep; 2006 Jun; 15(6):1469-75. PubMed ID: 16685381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Barrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation?
    Fitzgerald RC
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i21-6. PubMed ID: 15711004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors influencing the development of Barrett's epithelium in the esophageal remnant postesophagectomy.
    O'Riordan JM; Tucker ON; Byrne PJ; McDonald GS; Ravi N; Keeling PW; Reynolds JV
    Am J Gastroenterol; 2004 Feb; 99(2):205-11. PubMed ID: 15046206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Barrett's esophagus and adenocarcinoma.
    Reid BJ; Weinstein WM
    Annu Rev Med; 1987; 38():477-92. PubMed ID: 3555308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Barrett's esophagus. Comparison of benign and malignant cases.
    Skinner DB; Walther BC; Riddell RH; Schmidt H; Iascone C; DeMeester TR
    Ann Surg; 1983 Oct; 198(4):554-65. PubMed ID: 6625723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The sequential model of Barrett's esophagus and adenocarcinoma induced by duodeno-esophageal reflux without exogenous carcinogens.
    Sato T; Miwa K; Sahara H; Segawa M; Hattori T
    Anticancer Res; 2002; 22(1A):39-44. PubMed ID: 12017320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathophysiology and investigation of Barrett's esophagus.
    Reynolds RP
    Can J Gastroenterol; 1997 Sep; 11 Suppl B():41B-44B. PubMed ID: 9347177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barrett's Esophagus - State of the Art.
    Tanţău M; Laszlo M; Tanţău A
    Chirurgia (Bucur); 2018; 113(1):46-60. PubMed ID: 29509531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidative stress has a role in malignant transformation in Barrett's oesophagus.
    Sihvo EI; Salminen JT; Rantanen TK; Rämö OJ; Ahotupa M; Färkkilä M; Auvinen MI; Salo JA
    Int J Cancer; 2002 Dec; 102(6):551-5. PubMed ID: 12447994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Gastroesophageal reflux disease and malignancy].
    Richert Z; Robaszkiewicz M
    Rev Prat; 2008 Sep; 58(13):1414-5, 1417, 1419-20. PubMed ID: 18924321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
    Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
    Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis.
    Jankowski J; Hopwood D; Pringle R; Wormsley KG
    Am J Gastroenterol; 1993 Mar; 88(3):402-8. PubMed ID: 8438848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The columnar-lined (Barrett's) esophagus. Can progression to cancer be prevented?
    Stollman N
    Postgrad Med; 2000 Jun; 107(7):59-65; quiz 216. PubMed ID: 10887445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia.
    Wang DH; Clemons NJ; Miyashita T; Dupuy AJ; Zhang W; Szczepny A; Corcoran-Schwartz IM; Wilburn DL; Montgomery EA; Wang JS; Jenkins NA; Copeland NA; Harmon JW; Phillips WA; Watkins DN
    Gastroenterology; 2010 May; 138(5):1810-22. PubMed ID: 20138038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.